We are live on ! Find out more
EDIT icon

Editas Medicine

256 hedge funds and large institutions have $862M invested in Editas Medicine in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 82 increasing their positions, 67 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 67

8.24% less ownership

Funds ownership: 74.48%66.23% (-8.2%)

16% less funds holding

Funds holding: 305256 (-49)

20% less call options, than puts

Call options by funds: $31.2M | Put options by funds: $38.8M

36% less capital invested

Capital invested by funds: $1.35B → $862M (-$491M)

59% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 75

Holders
256
Holders Change
-49
Holders Change %
-16.07%
% of All Funds
4.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
31
Increased
82
Reduced
67
Closed
75
Calls
$31.2M
Puts
$38.8M
Net Calls
-$7.64M
Net Calls Change
+$19.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Capital Fund Management (CFM)
26
Capital Fund Management (CFM)
France
$6.99M +$2.15M +115,802 +46%
Rafferty Asset Management
27
Rafferty Asset Management
New York
$6.75M +$3.22M +173,292 +95%
CU
28
CQS (US)
New York
$6.41M +$6.26M +336,842 New
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$5.86M +$793K +42,641 +16%
Bank of America
30
Bank of America
North Carolina
$5.8M +$596K +32,084 +12%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$5.49M +$19.7K +1,060 +0.4%
SOMRS
32
State of Michigan Retirement System
Michigan
$5.21M
UBS Group
33
UBS Group
Switzerland
$4.59M +$1.86M +100,148 +71%
Assenagon Asset Management
34
Assenagon Asset Management
Luxembourg
$4.44M +$4.34M +233,487 New
Mirae Asset Global Investments
35
Mirae Asset Global Investments
South Korea
$4.13M -$814K -43,810 -17%
American Century Companies
36
American Century Companies
Missouri
$3.77M
Connor, Clark & Lunn Investment Management (CC&L)
37
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.47M +$2.02M +108,848 +148%
SCM
38
Shelton Capital Management
Colorado
$3.23M -$186K -10,000 -6%
Wells Fargo
39
Wells Fargo
California
$3.19M +$290K +15,609 +10%
Swiss National Bank
40
Swiss National Bank
Switzerland
$3.08M +$221K +11,900 +8%
RJA
41
Raymond James & Associates
Florida
$3.05M +$1.88M +100,971 +171%
NIA
42
NIA Impact Advisors
California
$2.93M +$1.22M +65,381 +74%
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$2.86M +$446K +23,967 +19%
Legal & General Group
44
Legal & General Group
United Kingdom
$2.48M +$333K +17,939 +16%
Lazard Asset Management
45
Lazard Asset Management
New York
$2.38M +$637K +34,249 +38%
Commonwealth Equity Services
46
Commonwealth Equity Services
Massachusetts
$2.21M -$88.9K -4,781 -4%
PAMS
47
Pictet Asset Management (Switzerland)
Switzerland
$2.08M +$187K +10,058 +10%
Group One Trading
48
Group One Trading
Illinois
$1.82M +$1.34M +72,329 +313%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$1.71M
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$1.67M -$135K -7,285 -8%

EDIT Hedge Fund Activity: Q1 2022 in Review

256 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2022, worth a combined $862M — down 36% from $1.35B a quarter earlier.

Sellers outnumbered buyers: 75 funds closed out of EDIT and 31 opened new positions — a net loss of 44 holders — while 67 trimmed existing stakes and 82 added.

The largest buyer was State Street, adding an estimated $41M. The largest seller was ARK Investment Management, cutting an estimated $63.6M.

  • 256 institutional investors held Editas Medicine (EDIT) as of Q1 2022, down from 305 in Q4 2021.
  • Funds reported $862M of Editas Medicine stock for Q1 2022, down 36% quarter-over-quarter.
  • 31 funds opened new Editas Medicine positions in Q1 2022 and 75 closed out, a net change of -44 holders.
  • The largest Editas Medicine buyer in Q1 2022 was State Street, an estimated $41M added.
  • The largest Editas Medicine seller in Q1 2022 was ARK Investment Management, an estimated $63.6M sold.

Based on aggregated 13F filings for Q1 2022.